Drug scheduling limits access to essential medicines and should be reformed. Comment from MasonMarksMD and CarmelShachar.
Even more concerning, the complex interaction between CSA enforcement, Food and Drug Administration approval and the patent system creates a pharmaceutical landscape that privileges high-cost synthetic compounds over naturally occurring
substances, while curtailing overall research. This system inhibits competition by granting monopolies to companies that develop proprietary therapeutics while discouraging subsequent research because of the challenges of gaining access to patented substances.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Community co-design to target diabetes and metabolic syndrome in Australian Indigenous peoples - Nature MedicineCommunity co-design to target diabetes and metabolic syndrome in Australian Indigenous peoples. Correspondence from Courtney Ryder and colleagues Flinders
続きを読む »
To Fight Superbugs, Farming and Medicine Must Change, U.N. SaysFarmers, drug makers and governments need to work together to curb the spread of drug-resistant bacteria and fungi, the United Nations says
続きを読む »
Superbugs Control Demands Change in Farming and Medicine, U.N. SaysDeaths from drug-resistant infections could rise from one million to 10 million annually by 2050 if antimicrobial resistance continues unchecked, the U.N. said Tuesday
続きを読む »
Thermal expansion and the glass transition - Nature PhysicsThe Lindemann criterion states that crystals melt when thermal vibrations overcome binding forces. It is now found that this picture does not hold for glasses, and that there is a universal relationship between glass temperature and thermal expansion.
続きを読む »